A Twelve Week Safety and Efficacy Study in Rosacea
Public ClinicalTrials.gov record NCT01784133. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate th safety and efficacy of one-daily topical application of CLS001 low, mid and high dose compared to vehicle gel in subjects with papulopustular rosacea.
Study identification
- NCT ID
- NCT01784133
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2013 (Type not available)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Not listed
- Last update posted
- May 20, 2015
Started 2013
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research Inc. | Birmingham | Alabama | 35209 | — |
| ATS Clinical Research | Santa Monica | California | 90404 | — |
| The Savin Center, PC | New Haven | Connecticut | 06511 | — |
| Skin Care Research, Inc | Boca Raton | Florida | 33486 | — |
| Dunedin Research Specialists | Dunedin | Florida | 34698 | — |
| North Florida Dermatology Associates | Jacksonville | Florida | 32204 | — |
| Dawes Fretzin Clinical Research Group | Indianapolis | Indiana | 46256 | — |
| Grekin Skin Institute | Warren | Michigan | 48088 | — |
| Rochester General Medical Group Center for Dermatology at Linden Oaks | Rochester | New York | 14625 | — |
| Derm Research Center of NY Inc. | Stoney Brook | New York | 11790 | — |
| Wake Resarch | Raleigh | North Carolina | 27612 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| TriCities Skin and Cancer | Johnson City | Tennessee | 37674 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| Progressive Clinical Research, PA | San Antonio | Texas | 78229 | — |
| Dermatology Research Center | Salt Lake City | Utah | 84117 | — |
| Virginia Clinical Research Inc. | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01784133, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2015 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01784133 live on ClinicalTrials.gov.